CLOT Conversations cover art

All Episodes

CLOT Conversations — 54 episodes

#
Title
1

Surgical and Procedural Bleed Risk Stratification in Anticoagulated Patients: ISTH Guidance in Practice

2

Which DOAC Bleeds Less? COBRRA Trial Insights for VTE Care with Dr Lana Castellucci

3

ARTESiA: Apixaban vs Aspirin Bleeding Risk with Dr D Siegal

4

WAVe Study: Cancer, Obesity, Anticoagulation with Dr Tzu-Fei Wang and Dr Gregoire Le Gal

5

ROXI-VTE Trials Explained: Dr. Jeff Weitz on Next-Generation Thrombosis Prevention

6

Diagnosing the “Second Clot”: Lessons from PREDICTORS with Dr Vicky Mai and Dr Grégoire Le Gal

7

Low Health Literacy in Pediatric Thrombosis: Clinical Risks and Realities - L. Avila and J. Vincelli

8

Children and PE: Outcomes You Need to Know - L. Avila and J. Vincelli

9

Navigating Thromboprophylaxis in Orthopedic Surgery

10

Risk Factors for Recurrent VTE in Cancer with Dr Faizan Khan

11

Mapping Cancer's Hidden Risk—A Global Look at Blood Clots

12

INVENT VTE Dragons Den

13

The COBRRA Study: Shifting Paradigms in Acute VTE Treatment

14

Breakthrough in DVT Diagnosis: Age-Adjusted D-Dimer Cutoff

15

COPD-PE Diagnosis & Recurrent VTE with Dr Vicky Mai

16

Oral anticoagulant drug considerations in Cancer: Dr Tzu-Fei Wang

17

Insights from Patient Experiences with VTE - Dr Stephanie Young

18

Breakthroughs in Thrombosis - research insights

19

Unlocking IVF Success - Dr Elvira Grandone

20

Reduced-Dose Apixaban for Cancer-Associated Thrombosis: A New Standard?

21

Taming the Bleed: An Algorithm for Action - Deborah Siegal & Siraj Mithoowani

22

Saving Money, Saving Lives: The Impact of Anticoagulation Stewardship - Dr Tony Wan

23

Canadian Stroke Best Practices - CVT

24

ANNEXA-4 G.I. Sub-analysis - Dr Deborah Siegal

25

ISTH 2023 COVID Guideline Update - Schulman & Sholzberg

26

Pharmacokinetics of DOACS after Bariatric Surgery - Gunka & Mithoowani

27

Spot The Clot in Cancer-associated Thrombosis - Dr Laurie Sardo & Julia Bayadinova, NP

28

Exploring Drug-Drug Interactions in Cancer Patients - Dr Tzu-Fei Wang

29

Post-thrombotic Syndrome and the TILE Study

30

ISTH Interview - Dr Gregoire Le Gal interviews Dr Vicky Mai

31

Interviews from the ISTH 2023

32

Statins & Post-thrombotic Syndrome - The Evidence

33

The HIGHLOW Study with Dr Saskia Middeldorp & Dr Hanke Wiegers

34

Thrombotic & Bleeding Outcomes following AC interruption in NVAF and Ca with Dr Joseph Shaw & Dr Tzu-Fei Wang

35

DOACs vs VKAs in thrombotic APS - Dr Jean Connors & Dr Behnood Bikdeli

36

Antithrombotic Stewardship with Dr Maral Koolian & Ryan Kerzner

37

Diagnosis & Mgmt of SCPCD with Dr M Othman & Dr L Brandao

38

Br J Haem VTE & COC Review and Meta-analysis Abdulrehman & Skeith

39

2022 CHEST Perioperative Guidelines with Dr J Douketis

40

mRNA COVID Vaccines & VTE with M Nicholson and N Chan

41

ISTH 2022 Day 4 Highlights with Thrombosis Canada

42

ISTH 2022 Day 3 Highlights with Thrombosis Canada

43

ISTH 2022 Day 2 Highlights with Thrombosis Canada

44

ISTH2022 Day 1 with Jameel Abdulrehman and Maha Othman

45

CCS 2022 PAD Guidelines with Dr Sonia Anand and Dr Eric Kaplovitch

46

New GI Guidelines on Management of GI Bleeds with Alan Barkun & Jim Douketis

47

The RAPID Trial - a discussion with Dr Michelle Sholzberg

48

Risk of VTE Recurrence with Subsegmental PE not anticoagulated

49

POISE-3 Tranexamic Acid in Noncardiac Surgery

50

Anti-seizure & Anticoagulant medications & interactions

51

Evaluation of definitions of OAC-associated major bleeding

52

Canadian Cancer-associated Thrombosis Algorithm Update 2021

53

Episode 1: Interview with Dr Sameer Parpia and Dr Kerstin De Wit

54

CLOT Conversations Intro